Invention Grant
- Patent Title: Serodiagnosis of lyme disease by use of two recombinant proteins in ELISA
-
Application No.: US15717470Application Date: 2017-09-27
-
Publication No.: US10401358B1Publication Date: 2019-09-03
- Inventor: Gary L. Bradshaw , R. Kelley Thueson , Todd Joseph Uriona
- Applicant: Ross Southern Laboratories
- Agency: Clayton Howarth, P.C.
- Main IPC: C07K14/20
- IPC: C07K14/20 ; C07K14/245 ; G01N33/569

Abstract:
Two Borrelia burgdorferi recombinant proteins were expressed in E. coli. These two proteins were generated from (a) the full length dbpA gene combined with the invariable region 6 of the VlsE gene (dbpA/C6), and (b) the full length OspC gene combined with the coding sequence for amino acids 1-121 of the E. coli maltose binding protein gene (OspC/MBP). Methods of using these recombinant proteins for detecting anti-Borrelia burgdorferi antibodies in patient sera and diagnosis of Lyme Disease are described.
Information query